Trial intelligence / Profile preview

CARTISTEM in knee cartilage defects

NCT01733186Phase 2Completed

Start
Jan 2013
Primary completion
Jun 2017
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of Cartistem in Articular cartilage defect. Started Jan 2013; status: completed.

02

Drugs

Cartistem
03

Conditions

Articular cartilage defect

Beyond the preview

Go deeper on NCT01733186.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01733186.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call